Shenzhen Kangtai Biological Products Co., Ltd.
SHZ: 300601.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xiang Miao
- Employees
- 1,913
- Headquarters
- Shenzhen, China
- IPO year
- 2017
- Market cap
- CN¥16.2B
- Website
- https://www.biokangtai.com
Loading 300601…
Loading profile data…Frequently asked questions about 300601
What does Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) do?
Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanu...
Where does 300601.SZ trade?
Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300601.SZ in?
Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shenzhen Kangtai Biological Products Co., Ltd.?
Xiang Miao is the chief executive officer of Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ).
Where is Shenzhen Kangtai Biological Products Co., Ltd. headquartered?
Shenzhen Kangtai Biological Products Co., Ltd. is headquartered in China.
Does 300601.SZ pay a dividend?
Yes — Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) paid a trailing twelve-month dividend of CNY 0.09 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300601.SZ go public?
Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) completed its initial public offering in 2017.